Dishman Pharmaceuticals and Chemicals Limited (DISHMAN):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH80629FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Dishman Pharmaceuticals and Chemicals Limited (Dishman) is a pharmaceutical company. It develops, manufactures and supplies Active Pharmaceutical Ingredients (API). The company offers a portfolio of development, scale-up and manufacturing services. The product portfolio of the company includes specialty chemicals; vitamins and chemicals; and disinfectants. It offers services such as contract research, contract manufacturing and API supply. Its specialty chemicals includes phase transfer catalysts, APIs, intermediates and fine chemicals; vitamins and chemicals include vitamin D2, vitamin D3, vitamin D analogues, cholesterol and lanolin product range; and disinfectants include antiseptic and disinfectant formulations. Its products are 24R, 25-dihydroxycholecalciferol, alfacalcidol / 1a-hydroxycholecalciferol, calcifediol / 25-hydroxycholecalciferol, monohydrate, calcitriol / 1a, 25-dihydroxycholecalciferol, cholecalciferol / vitamin D3, dihydrotachysterol-2 / DHT2, dohyfral D3-2000 AG, doxercalciferol / ercalcidol / 1a-hydroxyergocalciferol, ergocalciferol / vitamin D2, cholesterol HP, cholesterol NF, cholesterol SF, cholesterol XG, cholesteryl acetate, dusogel, dusoran MD and 7-dehydrocholesterol. It operates across India, China, Japan, the Netherlands, Switzerland, the UK and the US. Dishman is headquartered in Ahmedabad, Gujarat, India.

Dishman Pharmaceuticals and Chemicals Limited Key Recent Developments

Dec 30, 2013: Dishman Pharmaceuticals Announces Resignation of Company Secretary & Compliance Officer
Jul 31, 2013: Dishman Pharma Reports Revenue Of INR898.7m In Q1 Fiscal 2014
Jul 03, 2013: Dishman Pharma Appoints Mark Griffiths As CEO
May 28, 2013: Dishman Pharma Reports Revenue Of INR12.7 Billion In Fiscal 2013
Feb 11, 2013: Dishman Pharma Reports Revenue Of INR3.2 Billion In Q3 Fiscal 2013

This comprehensive SWOT profile of Dishman Pharmaceuticals and Chemicals Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dishman Pharmaceuticals and Chemicals Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dishman Pharmaceuticals and Chemicals Limited – Key Information
Dishman Pharmaceuticals and Chemicals Limited – Overview
Dishman Pharmaceuticals and Chemicals Limited – Key Employees
Dishman Pharmaceuticals and Chemicals Limited – Key Employee Biographies
Dishman Pharmaceuticals and Chemicals Limited – Key Operational Heads
Dishman Pharmaceuticals and Chemicals Limited – Major Products and Services
Dishman Pharmaceuticals and Chemicals Limited – History
Dishman Pharmaceuticals and Chemicals Limited – Company Statement
Dishman Pharmaceuticals and Chemicals Limited – Locations And Subsidiaries
Dishman Pharmaceuticals and Chemicals Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dishman Pharmaceuticals and Chemicals Limited – Business Description
Dishman Pharmaceuticals and Chemicals Limited – Corporate Strategy
Dishman Pharmaceuticals and Chemicals Limited – SWOT Analysis
SWOT Analysis – Overview
Dishman Pharmaceuticals and Chemicals Limited – Strengths
Dishman Pharmaceuticals and Chemicals Limited – Weaknesses
Dishman Pharmaceuticals and Chemicals Limited – Opportunities
Dishman Pharmaceuticals and Chemicals Limited – Threats
Dishman Pharmaceuticals and Chemicals Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Dishman Pharmaceuticals and Chemicals Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dishman Pharmaceuticals and Chemicals Limited, Key Information
Dishman Pharmaceuticals and Chemicals Limited, Key Ratios
Dishman Pharmaceuticals and Chemicals Limited, Share Data
Dishman Pharmaceuticals and Chemicals Limited, Major Products and Services
Dishman Pharmaceuticals and Chemicals Limited, History
Dishman Pharmaceuticals and Chemicals Limited, Key Employees
Dishman Pharmaceuticals and Chemicals Limited, Key Employee Biographies
Dishman Pharmaceuticals and Chemicals Limited, Key Operational Heads
Dishman Pharmaceuticals and Chemicals Limited, Other Locations
Dishman Pharmaceuticals and Chemicals Limited, Subsidiaries
Dishman Pharmaceuticals and Chemicals Limited, Key Manufacturing facilities
Dishman Pharmaceuticals and Chemicals Limited, Key Competitors
Dishman Pharmaceuticals and Chemicals Limited, SWOT Analysis
Dishman Pharmaceuticals and Chemicals Limited, Ratios based on current share price
Dishman Pharmaceuticals and Chemicals Limited, Annual Ratios
Dishman Pharmaceuticals and Chemicals Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Dishman Pharmaceuticals and Chemicals Limited, Performance Chart
Dishman Pharmaceuticals and Chemicals Limited, Ratio Charts

★海外企業調査レポート[Dishman Pharmaceuticals and Chemicals Limited (DISHMAN):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VitamFero SA(製薬・医療分野):企業M&A動向
    Summary VitamFero SA (VitamFero) is a biotechnology company. The company develops, registers and markets anti-infectious vaccines. Its products include toxoplasmosis vaccine, neosporosis vaccine and cryptosporidiosis. It participates in the development of anti-parasite vaccines satisfying unmet need …
  • Phynova Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Phynova Group plc Mergers and A …
  • Brembo SpA:戦略・SWOT・企業財務分析
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sky Deutschland GmbH:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Sky Deutschland GmbH" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly foll …
  • B.M.P. Pharma Trading AG (BMP):企業概要、財務及び戦略的SWOT分析
    Summary B.M.P. Pharma Trading AG (B.M.P) is a pharmaceutical company. The company distributes nutraceutical products and pharmaceutical raw materials. It provides products, such as analgin, atenolol, atropin sulfate, azithromycin, benzylbenzoat, betamethasone, valerate, biotin, boric acid, caffeine …
  • Traverse Energy Ltd. (TVL)(石油・ガス分野):企業M&A動向
    Summary Traverse Energy Ltd. (Traverse Energy) is an oil and natural gas company. The company explores, develops and produces petroleum and natural gas in Canada. It has oil and natural gas properties located in Alliance, Brazeau ORR, Carbon, Long Coulee, Minor ORR and Turin. Traverse participates i …
  • medac GmbH:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' medac GmbH Mergers and Acquisit …
  • Housing Development and Infrastructure Ltd.:企業の戦略・SWOT・財務分析
    SummaryHousing Development and Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Time Warner Inc.:企業の戦略・SWOT・財務分析
    SummaryTime Warner Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Probe Scientific Ltd-医療機器分野:企業M&A・提携分析
    Summary Probe Scientific Ltd (Probe Scientific) is a medical device company that develops products to solve clinical issues. The company offers products, which include microeye, continumon and nanoeye, among others. Its microeye is a sampling device for monitoring substances such as electrolytes, am …
  • BioCryst Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioCryst Pharmaceuticals, Inc. …
  • Kanematsu Corporation (8020):企業財務及び戦略的SWOT分析
    Summary Kanematsu Corporation (Kanematsu) is a technology company that trades various commercial products. The company operates through its business segments such as electronics and devices, foods and grain, steel, materials and plants, and motor vehicles and aerospace. Its electronic and devices se …
  • Drax Group Plc (DRX):企業の財務・戦略的SWOT分析
    Drax Group Plc (DRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Deutsche Lufthansa AG:企業概要・SWOT・財務分析
    Summary Canadean's "Deutsche Lufthansa AG : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descrip …
  • Shanghai Industrial Urban Development Group (563):企業概要、財務及び戦略的SWOT分析
    Summary Shanghai Industrial Urban Development Group (Shanghai Industrial) is an investment holding company. The company invests in real estate development, operation and other related businesses. It carries out property investment, property development, and hotel operation. Shanghai Industrial offer …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corporation Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Nuevolution A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nuevolution A/S Mergers and Acq …
  • Yabao Pharmaceutical Group Co., Ltd. (600351):企業概要、財務及び戦略的SWOT分析
    Summary Yabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company. The company manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs, and health care products. Its products include sennae leaf, senna pods, clove, rhubarb, compou …
  • MicroTransponder Inc.:企業のM&A・提携動向(医療機器分野)
    Summary MicroTransponder Inc. (MicroTransponder) is a medical device company that develops paired vagus nerve stimulation system (VNS) to treat several neurological diseases. The company's paired VNS System is used in two clinical trials for treating tinnitus and upper limb mobility issues for strok …
  • Condor Petroleum Inc (CPI)-石油・ガス分野:企業M&A・提携分析
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆